When to Stop Routine Screening and Laboratory Testing
For individuals up-to-date with prior screening, stop routine colorectal cancer screening at age 75 or when life expectancy falls below 10 years; for those never screened, consider screening up to age 85 based on comorbidities, but discontinue all screening after age 85. 1
Age-Based Stopping Points by Screening Type
Colorectal Cancer Screening
The most recent U.S. Multi-Society Task Force guidelines (2022) provide clear stopping criteria 1:
- Age 75 with negative prior screening: Stop routine screening if previously up-to-date, particularly with high-quality colonoscopy (weak recommendation, low-quality evidence)
- Ages 76-85 without prior screening: Individualize decisions based on comorbidities and overall health status
- After age 85: Actively discourage continued screening (qualified recommendation)
The USPSTF (2021) aligns closely, giving a Grade C recommendation for selective screening ages 76-85, emphasizing that net benefit is small and decisions should incorporate overall health, prior screening history, and patient preferences 2.
Cervical Cancer Screening
Guidelines generally recommend stopping at age 65 for women with adequate prior negative screening (typically 3 consecutive negative cytology results or 2 consecutive negative co-testing results within 10 years, with the most recent test within 5 years).
Breast Cancer Screening
Most guidelines suggest stopping routine mammography at age 75, with individualized decisions thereafter based on life expectancy and health status.
Prostate Cancer Screening
Screening should generally stop at age 70-75, as harms increasingly outweigh benefits beyond this age due to high rates of overdiagnosis 3.
Critical Decision Framework
Life expectancy is the key determinant, not chronological age alone. Use this algorithm:
Calculate estimated life expectancy based on:
- Comorbidity burden (none, mild, moderate, severe)
- Functional status (ADLs, IADLs)
- Overall health status
Apply the 10-year rule: If life expectancy < 10 years, stop screening 1, 4
Adjust stopping age by comorbidity level 4:
- No comorbidities: Screen until age 76
- Mild comorbidities: Screen until age 74
- Moderate comorbidities: Screen until age 72
- Severe comorbidities: Screen until age 66
Important Caveats
Prior screening history matters significantly. The recommendations differ dramatically between those who have been regularly screened versus never-screened individuals. Someone who has never been screened may benefit from screening even into their early 80s, while someone with consistently negative prior tests should stop at 75 1.
The "time to benefit" concept is crucial. Cancer screening requires years before mortality benefits emerge—approximately 7-10 years for most cancers 5. An average 75-year-old stopping mammography or fecal occult blood testing gives up only 9 days of maximum potential life expectancy; at age 80, only 5 days 5.
Beware of inappropriate screening in the elderly. Research shows that cancer screening remains common among older adults with multimorbidity and polypharmacy—precisely the population least likely to benefit 6. Those with 4+ morbidities or polypharmacy have 54-66% higher screening rates despite shorter life expectancy, representing potential overuse.
Practical Implementation
For patients age 75+, ask these questions:
- What is their prior screening history? (up-to-date vs. never screened)
- What is their estimated life expectancy? (use comorbidity indices)
- Do they have functional limitations affecting daily activities?
- What are their preferences regarding additional testing and potential treatment?
Hard stop at age 85: Regardless of health status or screening history, actively recommend discontinuing all routine cancer screening after age 85, as harms definitively outweigh benefits 1.